Cryo-EM structures of Nav channels with pore-blocking inhibitors resolved
| PDB ID | Emd ID | Drug ID | Reference | Drug name | Drug Qscores | Ave.pore Qscores | Subtype |
|---|---|---|---|---|---|---|---|
| 7W77 | 32341 | 966 | Li et al. (2022) | Bulleyaconitine A | 0.391 | 0.52 | Human Nav1.3 |
| 7W7F | 32343 | 8DE | Li et al. (2022) | ICA-121431 | 0.409 | 0.489 | Human Nav1.3 |
| 6UZ0 | 20949 | K4D | Jiang et al. (2020) | Flecainidea | 0.557 | 0.527 | rat Nav1.5 |
| 6LQA | 942 | QDN | Li et al. (2021) | Quinidine | 0.529 | 0.523 | Human Nav1.5 |
| 7FBS | 31519 | 4Y4 | Jiang et al. (2021) | Propafenone | 0.556 | 0.57 | rat Nav1.5 |
| 8F6P | 28887 | XHO | Lenaeus et al. (2023) | Ranolazine | 0.512 | 0.556 | rat Nav1.5 |
| 8T6L | 41071 | YIJ | Tonggu et al. (2024) | Batrachotoxin, Analog BTX-B | 0.253, 0.31 | 0.545 | rat Nav1.5 |
| 7XM9 | 33292 | G2E | Zhang et al. (2022) | XEN-907 | 0.483 | 0.541 | Human Nav1.7 |
| 7XMF | 33295 | G2W | Zhang et al. (2022) | IN2 | 0.463 | 0.563 | Human Nav1.7 |
| 7XMG | 33296 | G4I | Zhang et al. (2022) | TCN-1752 | 0.57 | 0.542 | Human Nav1.7 |
| 8I5B | 35193 | OJ0 | Wu et al. (2023) | Bupivacaine | 0.4 | 0.634 | Human Nav1.7 |
| 8I5G | 35194 | T70 | Wu et al. (2023) | PF-05089771 | 0.64 | 0.647 | Human Nav1.7 |
| 8I5X | 35197 | T7F | Wu et al. (2023) | Vinpocetine | 0.494 | 0.604 | Human Nav1.7 |
| 8I5Y | 35198 | TB4 | Wu et al. (2023) | Vixotrigine | 0.577 | 0.657 | Human Nav1.7 |
| 8J4F | 35975 | UK0 | Wu et al. (2023) | Hardwickii acid | 0.555 | 0.594 | Human Nav1.7 |
| 8S9B | 40238 | LQO | Wu et al. (2023) | Lacosamidea | 0.665, 0.534 | 0.596 | Human Nav1.7 |
| 8S9C | 40239 | N6W | Wu et al. (2023) | Carbamazepine | 0.56 | 0.577 | Human Nav1.7 |
| 8G1A | 29665 | P0T | Huang et al. (2023a) | Cannabidiol | 0.491, 0.364 | 0.573 | Human Nav1.7 |
| 8THH | 41262 | IYJ | Huang et al. (2023b) | Lamotriginea | 0.589, 0.456 | 0.615 | Human Nav1.7 |
| 8THG | 41261 | 657 | Huang et al. (2023b) | Riluzolea | 0.582 | 0.584 | Human Nav1.7 |
| 7WE4 | 32439 | 95T | Huang et al. (2022) | A-803467 | 0.659 | 0.609 | Human Nav1.8 |
| PDB ID | Emd ID | Drug ID | Reference | Drug name | Drug Qscores | Ave.pore Qscores | Subtype |
|---|---|---|---|---|---|---|---|
| 32341 | 966 | Bulleyaconitine A | 0.391 | 0.52 | Human Nav1.3 | ||
| 32343 | 8DE | ICA-121431 | 0.409 | 0.489 | Human Nav1.3 | ||
| 20949 | K4D | Flecainide | 0.557 | rat Nav1.5 | |||
| 942 | QDN | Quinidine | 0.529 | Human Nav1.5 | |||
| 31519 | 4Y4 | Propafenone | 0.556 | 0.57 | rat Nav1.5 | ||
| 28887 | XHO | Ranolazine | 0.512 | 0.556 | rat Nav1.5 | ||
| 41071 | YIJ | Batrachotoxin, Analog BTX-B | 0.253, 0.31 | 0.545 | rat Nav1.5 | ||
| 33292 | G2E | XEN-907 | 0.483 | 0.541 | Human Nav1.7 | ||
| 33295 | G2W | IN2 | 0.463 | 0.563 | Human Nav1.7 | ||
| 33296 | G4I | TCN-1752 | 0.57 | Human Nav1.7 | |||
| 35193 | OJ0 | Bupivacaine | 0.634 | Human Nav1.7 | |||
| 35194 | T70 | PF-05089771 | 0.64 | 0.647 | Human Nav1.7 | ||
| 35197 | T7F | Vinpocetine | 0.494 | 0.604 | Human Nav1.7 | ||
| 35198 | TB4 | Vixotrigine | 0.577 | 0.657 | Human Nav1.7 | ||
| 35975 | UK0 | Hardwickii acid | 0.555 | 0.594 | Human Nav1.7 | ||
| 40238 | LQO | Lacosamide | 0.665, | Human Nav1.7 | |||
| 40239 | N6W | Carbamazepine | 0.56 | 0.577 | Human Nav1.7 | ||
| 29665 | P0T | Cannabidiol | 0.573 | Human Nav1.7 | |||
| 41262 | IYJ | Lamotrigine | 0.589, | 0.615 | Human Nav1.7 | ||
| 41261 | 657 | Riluzole | 0.582 | 0.584 | Human Nav1.7 | ||
| 32439 | 95T | A-803467 | 0.659 | Human Nav1.8 |
Q-scores were extracted from Electron Microscopy Data Bank (https://www.ebi.ac.uk/emdb/) validation reports. Q-scores are used as a measure of resolvability in regions of a cryo-EM map – smaller the q-score, the lower the resolvability.
Indicates the instances where the averaged q-score of the surrounding pore residues is lower than the drug’s q-score. Bold indicates drug molecules not bound in the pore, but rather identified below the intracellular gate.
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Please sign in to your personal account to gift article access.
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses.
You have reached the limit of 10 links within a 30 day period.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.